Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The drug Caplyta, owned by Intra-Cellular Therapies, is being used to treat bipolar disorder and schizophrenia. In 2024, it brought in more than $481 million in sales.
The companies argue that the U.S. Department of Justice has failed to adequately demonstrate how, and in which regions of the country, the merger would harm competition. They are asking a federal court to throw out the case.
The motion is being advanced by religious groups and hedge funds alike, with the decision to develop a report set to be voted on at the UnitedHealth Group 2025 annual meeting.
Error in diagnosis is the most common reason for lawsuits against radiologists in the United States, according to results from a study published in Radiology
The Wall Street Journal reports that Varian Medical Systems lobbied for Medicare payment cuts to its direct competitor, Elekta, a Swedish manufacturer of radiation tools
Overall spending for health care mergers and acquisitions fell by 38% in 2012, even as the total number of deals rose slightly, finds Irving Levin Associates report